US 10881660
Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists
granted A61KA61K31/513A61P
Quick answer
US patent 10881660 (Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists) held by Corcept Therapeutics Incorporated expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Jan 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/513, A61P, A61P1/16